EUVIMEDEUVIMED entdecken
Fallbericht

Anti-A Antibody Rebound–Induced Thrombotic Microangiopathy After ABO-Incompatible Kidney Transplantation: A Case Report

Yukihiro Hitaka, Naohito Isoyama, Megumi Tanaka, Yoshimasa Ban, Masashi Ogawa, Mitsuhiro Yamaguchi, Kimihiko Nakamura, Toshiya Hiroyoshi, Masayuki Tasaki, Noriko Uesugi, Koji Shiraishi

Transplantation Proceedings · 2026-06 · 58 (5) · 854-858

DOI: 10.1016/j.transproceed.2026.03.029 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Transplantation Proceedings, 2026-06. Verfasst von Yukihiro Hitaka und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan. Electronic address: h.yukki@yamaguchi-u.ac.jp. Hauptthemen laut MEDLINE: Kidney Transplantation, ABO Blood-Group System, Thrombotic Microangiopathies, Blood Group Incompatibility. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND ABO-incompatible kidney transplantation (ABOi-KT) expands donor availability, but postoperative anti-ABO antibody rebound can lead to rare complications such as thrombotic microangiopathy (TMA), often resulting in graft loss. CASE PRESENTATION A 61-year-old underwent ABOi-KT (A → B) after standard desensitization. Despite achieving pre-transplant anti-A IgG and IgM titers of 1:1, a marked postoperative rebound occurred, with both titers rising to 1:1024 by postoperative day 6, accompanied by TMA and acute rejection manifesting as elevated serum creatinine (sCre) (maximum 8.63 mg/dL). Notably, overt hemolytic markers and thrombocytopenia were absent. Management included intensified plasma exchange, intravenous immunoglobulin, high-dose steroids, and discontinuation of tacrolimus. sCre peaked at 8.63 mg/dL, later stabilizing to ∼5 mg/dL at 1 year without dialysis. CONCLUSIONS Despite adequate desensitization, anti-A antibody rebound can cause early TMA. Importantly, early recognition and aggressive multimodal treatment can rescue the graft, avoiding the high likelihood of graft loss. This case highlights the importance of antibody surveillance after ABOi-KT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationABO Blood-Group SystemThrombotic MicroangiopathiesBlood Group IncompatibilityHumansMiddle AgedMaleImmunosuppressive AgentsPlasma ExchangeGraft Rejection

Substanzen

ABO Blood-Group SystemImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan. Electronic address: h.yukki@yamaguchi-u.ac.jp.
  • Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan.
  • Department of Urology, Molecular Oncology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
  • Department of Pathology, Fukuoka University School of Medicine, Fukuoka, Japan.

Zitieren

APA

Hitaka, Y., Isoyama, N., Tanaka, M., Ban, Y., Ogawa, M., Yamaguchi, M., Nakamura, K., Hiroyoshi, T., Tasaki, M., Uesugi, N., & Shiraishi, K. (2026). Anti-A Antibody Rebound–Induced Thrombotic Microangiopathy After ABO-Incompatible Kidney Transplantation: A Case Report. Transplantation Proceedings, 58(5), 854-858. https://doi.org/10.1016/j.transproceed.2026.03.029

Vancouver

Hitaka Y, Isoyama N, Tanaka M, Ban Y, Ogawa M, Yamaguchi M, et al. Anti-A Antibody Rebound–Induced Thrombotic Microangiopathy After ABO-Incompatible Kidney Transplantation: A Case Report. Transplantation Proceedings. 2026;58(5):854-858. doi:10.1016/j.transproceed.2026.03.029

BibTeX
@article{Hitaka2026,
  author = {Hitaka, Yukihiro and Isoyama, Naohito and Tanaka, Megumi and Ban, Yoshimasa and Ogawa, Masashi and Yamaguchi, Mitsuhiro and Nakamura, Kimihiko and Hiroyoshi, Toshiya and Tasaki, Masayuki and Uesugi, Noriko and Shiraishi, Koji},
  title = {Anti-A Antibody Rebound–Induced Thrombotic Microangiopathy After ABO-Incompatible Kidney Transplantation: A Case Report},
  journal = {Transplantation Proceedings},
  year = {2026},
  volume = {58},
  number = {5},
  pages = {854--858},
  doi = {10.1016/j.transproceed.2026.03.029}
}
Kostenlos starten →